发明名称 |
Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination |
摘要 |
Disclosed is a pharmaceutical composition comprising a pyrazine derivative represented by the general formula:;
[wherein R1 and R2 independently represent a hydrogen atom or a halogen atom; and R3 represents a hydrogen atom or an amino-protecting group] or a salt thereof and at least one neuraminidase inhibitor. The pharmaceutical composition is useful for a treatment including the treatment or prevention of influenza. Also disclosed is a method of using these components in combination. The method is useful for a treatment including the treatment or prevention of influenza. |
申请公布号 |
US8759354(B2) |
申请公布日期 |
2014.06.24 |
申请号 |
US200812527260 |
申请日期 |
2008.02.14 |
申请人 |
Toyama Chemical Co., Ltd. |
发明人 |
Maekawa Masako |
分类号 |
A61K31/4965;A61K31/35;A61K31/22;A61K31/225 |
主分类号 |
A61K31/4965 |
代理机构 |
Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P. |
代理人 |
Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P. |
主权项 |
1. A pharmaceutical composition for treating influenza virus infection, comprising (A) a pyrazine derivative represented by the following general formula or a salt thereof; and (B) a neuraminidase inhibitor selected from the group consisting oseltamivir, zanamivir, peramivir, and CS-8958: wherein R1 is a hydrogen atom, R2 is fluorine, and R3 is a hydrogen atom, and wherein (A) and (B) are in synergistic and effective amounts.
|
地址 |
Tokyo JP |